Loading institutional data...
Loading institutional data...
Institutional accumulation: ownership increased +1.52% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $24.66 today, the market must believe free cash flow compounds 10.2%/yr for a decade (off $7M normalized FCF).
The market's 10.2% is more optimistic than its 9-yr track record.
2-stage DCF · 0.01B shares · net debt $26M
mean 99.5% · volatility σ 202% · implied rate exceeded in 2/4 yrs
Central path = implied 10.2%/yr growth; shaded band = ±1σ (202%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $28.75T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $364.2B | 41.6× | 29.1× | 5.4× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.2B | 38.4× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $264.2B | 39.7× | 18.8× | 3.0× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $204.4B | 81.4× | 41.0× | 2.3× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $181.0B | 36.2× | — | 4.0× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $174.3B | 47.1× | 31.1× | 5.4× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $166.7B | 23.4× | 16.0× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $154.3B | 38.1× | — | 5.6× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.9B | 28.2× | 16.2× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.0B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $117.9B | 33.9× | 26.6× | 5.9× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.7B | 25.0× | — | 5.0× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $97.3B | 23.3× | 17.1× | 1.9× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.0B | 32.5× | 23.2× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| PWR | $92.6B | 91.1× | 46.0× | 3.3× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| VRT | $91.6B | 70.2× | 43.4× | 8.9× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| JCI | $91.6B | 27.9× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $91.5B | 61.4× | 40.3× | 11.1× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $86.2B | 27.1× | 16.6× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.2B | 31.9× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $83.9B | 15.1× | 9.4× | 0.9× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $82.1B | 36.1× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $80.4B | 45.3× | 28.9× | 7.8× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| EML | $153M | 21.6× | 12.4× | 0.6× | -8.7% | 22.9% | 2.9% | 5.7% | 4.5% | 2.3× | 71 |
Peers = companies sharing EML's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2024 | FY2023 | FY2023 | FY2022 | FY2022 | FY2021 | FY2021 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $249.0M 100.0% | $272.8M 100.0% | — | $258.9M 100.0% | $279.3M 100.0% | $246.5M 100.0% | $246.5M 100.0% | $197.6M 100.0% | $251.7M 100.0% | $234.3M 100.0% |
| Cost of Revenue | $192.0M 77.1% | $205.5M 75.3% | — | $197.1M 76.1% | $220.6M 79.0% | $189.8M 77.0% | — | $149.5M 75.7% | $189.9M 75.4% | $175.6M 74.9% |
| Gross Profit | $57.0M 22.9% | $67.3M 24.7% | — | $61.8M 23.9% | $58.6M 21.0% | $56.8M 23.0% | — | $48.1M 24.3% | $61.9M 24.6% | $58.7M 25.1% |
| Research & Development | $4.1M 1.6% | $4.9M 1.8% | — | $5.6M 2.2% | $4.2M 1.5% | $4.1M 1.7% | — | $2.7M 1.4% | $6.0M 2.4% | $7.0M 3.0% |
| Selling, General & Admin | $42.2M 17.0% | $42.2M 15.5% | — | $39.1M 15.1% | $39.5M 14.1% | $35.2M 14.3% | — | $30.2M 15.3% | $35.7M 14.2% | $33.9M 14.5% |
| Operating Income | $10.7M 4.3% | $20.1M 7.4% | — | $17.0M 6.6% | $14.2M 5.1% | $17.4M 7.1% | — | $13.5M 6.8% | $17.5M 6.9% | $17.9M 7.6% |
| Interest Expense | $2.7M 1.1% | $2.7M 1.0% | — | $2.8M 1.1% | $2.3M 0.8% | $1.7M 0.7% | — | $2.1M 1.0% | $1.9M 0.7% | $1.2M 0.5% |
| Other Income (Expense), net | -$499K -0.2% | -$353K -0.1% | — | $855K 0.3% | $2.5M 0.9% | $3.4M 1.4% | — | $1.8M 0.9% | $606K 0.2% | $933K 0.4% |
| Pretax Income | $7.5M 3.0% | $17.1M 6.3% | — | $15.1M 5.8% | $14.4M 5.2% | $19.1M 7.7% | $19.1M 7.7% | $13.2M 6.7% | $16.2M 6.4% | $17.6M 7.5% |
| Income Tax Expense | $1.5M 0.6% | $3.9M 1.4% | — | $3.3M 1.3% | -$3.4M -1.2% | -$2.1M -0.9% | — | $1.6M 0.8% | $2.9M 1.2% | $3.1M 1.3% |
| Net Income | $7.1M 2.9% | -$8.5M -3.1% | $8.6M | $8.6M 3.3% | $12.3M 4.4% | $9.3M 3.8% | — | $5.4M 2.7% | $13.3M 5.3% | $14.5M 6.2% |
| Per Share | ||||||||||
| EPS (Basic) | $1.17 | $-1.37 | — | $1.38 | $1.98 | $1.49 | — | $1.77 | $2.13 | $2.32 |
| EPS (Diluted) | $1.17 | $-1.37 | — | $1.37 | $1.97 | $1.49 | — | $1.76 | $2.12 | $2.31 |
| Weighted Avg Shares (Basic) | 6.1M | 6.2M | — | 6.2M | 6.2M | 6.3M | 6.3M | 6.2M | 6.2M | 6.3M |
| Weighted Avg Shares (Diluted) | 6.1M | 6.2M | — | 6.3M | 6.2M | 6.3M | 6.3M | 6.3M | 6.3M | 6.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 55% of free cash flow, leaving room to grow it and fund buybacks. Last year: $3M dividends + $4M buybacks = $6M returned on $5M FCF.
2 consecutive years of dividend increases · 0%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $7M covers the $3M due within a year 2.6× over. Scheduled principal only (excludes interest & revolver draws). As of 2023-12-30 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~7.9% on $34M of debt.
Cash of $7M fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
No material risks flagged.
Where each multiple sits in its own 4-yr range · 58th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 4-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 5.4× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2021 | FY2021 | FY2022 | FY2022 | FY2023 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 75.7 | — | 77.0 | 79.0 | 76.1 | — | 75.3 | 77.1 |
| Gross Profit | 24.3 | — | 23.0 | 21.0 | 23.9 | — | 24.7 | 22.9 |
| R&D | 1.4 | — | 1.7 | 1.5 | 2.2 | — | 1.8 | 1.6 |
| SG&A | 15.3 | — | 14.3 | 14.1 | 15.1 | — | 15.5 | 17.0 |
| Operating Income | 6.8 | — | 7.1 | 5.1 | 6.6 | — | 7.4 | 4.3 |
| Income Tax | 0.8 | — | -0.9 | -1.2 | 1.3 | — | 1.4 | 0.6 |
| Net Income | 2.7 | — | 3.8 | 4.4 | 3.3 | — | -3.1 | 2.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on EML: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.